Malignant mixed Mullerian tumor

Active Research Protocols

  1. 11-C-0022 – A Pharmacokinetic/Pharmacodynamic Study with a Phase I Run-In with a PARP Inhibitor (Olaparib) in Combination with Carboplatin for Refractory or Recurrent Women's Cancers
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014